Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET)

CUSIP: 007002108

Q4 2023 13F Holders as of 31 Dec 2023

Type / Class
Equity / Common Stock, par value $0.0001
Shares outstanding
9,599,852
Total 13F shares
33,363,531
Share change
-2,113,650
Total reported value
$63,033,300
Put/Call ratio
1024%
Price per share
$1.89
Number of holders
76
Value change
-$3,182,870
Number of buys
34
Number of sells
39

Quarterly Holders Quick Answers

What is CUSIP 007002108?
CUSIP 007002108 identifies ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ACET - Adicet Bio, Inc. - Common Stock, par value $0.0001 (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
ORBIMED ADVISORS LLC
13F
Company
87%
8,322,140
$11,401,332 30 Sep 2023
13F
RTW INVESTMENTS, LP
13F
Company
44%
4,241,472
$5,810,817 30 Sep 2023
13F
MORGAN STANLEY
13F
Company
40%
3,836,377
$5,255,836 30 Sep 2023
13F
COWEN AND COMPANY, LLC
13F
Company
28%
2,715,278
$3,719,930 30 Sep 2023
13F
BlackRock Finance, Inc.
13F
Company
24%
2,269,478
$3,109,184 30 Sep 2023
13F
Carlyle Group Inc.
13F
Company
22%
2,115,385
$2,876,924 30 Sep 2023
13F
VANGUARD GROUP INC
13F
Company
17%
1,672,386
$2,291,169 30 Sep 2023
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
13%
1,226,352
$1,680,102 30 Sep 2023
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
9.3%
893,882
$1,224,618 30 Sep 2023
13F
DAFNA Capital Management LLC
13F
Company
8.3%
797,054
$1,091,964 30 Sep 2023
13F
JOHNSON & JOHNSON
13F
Company
7.6%
728,944
$998,653 30 Sep 2023
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
7.1%
677,000
$927,000 30 Sep 2023
13F
STATE STREET CORP
13F
Company
6.6%
633,533
$867,940 30 Sep 2023
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
6.6%
632,954
$867,263 30 Sep 2023
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
5.4%
523,009
$715,000 30 Sep 2023
13F
NORGES BANK
13F
Company
4.5%
429,550
$588,484 30 Sep 2023
13F
TWO SIGMA ADVISERS, LP
13F
Company
4%
386,696
$529,774 30 Sep 2023
13F
JACOBS LEVY EQUITY MANAGEMENT, INC
13F
Company
3.5%
333,593
$457,022 30 Sep 2023
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
2.6%
249,200
$341,404 30 Sep 2023
13F
D. E. Shaw & Co., Inc.
13F
Company
2.6%
244,873
$335,476 30 Sep 2023
13F
NORTHERN TRUST CORP
13F
Company
2.4%
230,401
$315,649 30 Sep 2023
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
2.3%
225,316
$308,683 30 Sep 2023
13F
Decheng Capital Management III (Cayman), LLC
13F
Company
2.1%
200,201
$274,275 30 Sep 2023
13F
Nuveen Asset Management, LLC
13F
Company
1.7%
162,792
$223,025 30 Sep 2023
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
1.7%
160,905
$220,545 30 Sep 2023
13F
MARSHALL WACE, LLP
13F
Company
1.6%
152,508
$208,937 30 Sep 2023
13F
GSA CAPITAL PARTNERS LLP
13F
Company
1.5%
142,168
$195,000 30 Sep 2023
13F
Acuitas Investments, LLC
13F
Company
1.4%
136,779
$187,387 30 Sep 2023
13F
FMR LLC
13F
Company
1.4%
135,998
$186,317 30 Sep 2023
13F
Bank of New York Mellon Corp
13F
Company
1.4%
131,393
$180,009 30 Sep 2023
13F
CITADEL ADVISORS LLC
13F
Company
1%
99,017
$135,653 30 Sep 2023
13F
OCCUDO QUANTITATIVE STRATEGIES LP
13F
Company
0.85%
81,129
$111,147 30 Sep 2023
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.78%
75,022
$102,780 30 Sep 2023
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.72%
69,460
$95,160 30 Sep 2023
13F
EXCHANGE TRADED CONCEPTS, LLC
13F
Company
0.64%
61,196
$83,839 30 Sep 2023
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.62%
59,650
$81,721 30 Sep 2023
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.62%
59,511
$81,530 30 Sep 2023
13F
XTX Topco Ltd
13F
Company
0.58%
55,609
$76,184 30 Sep 2023
13F
RHUMBLINE ADVISERS
13F
Company
0.48%
46,458
$63,638 30 Sep 2023
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.47%
45,436
$62,247 30 Sep 2023
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.42%
40,540
$55,540 30 Sep 2023
13F
CORNERCAP INVESTMENT COUNSEL INC
13F
Company
0.4%
38,209
$52,346 30 Sep 2023
13F
Cubist Systematic Strategies, LLC
13F
Company
0.33%
31,745
$43,491 30 Sep 2023
13F
Marquette Asset Management, LLC
13F
Company
0.29%
28,144
$38,558 30 Sep 2023
13F
JPMORGAN CHASE & CO
13F
Company
0.29%
27,976
$38,327 30 Sep 2023
13F
Squarepoint Ops LLC
13F
Company
0.28%
26,415
$36,189 30 Sep 2023
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.23%
21,791
$29,854 30 Sep 2023
13F
Summit Trail Advisors, LLC
13F
Company
0.19%
18,000
$24,660 30 Sep 2023
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.16%
15,167
$20,779 30 Sep 2023
13F
SIMPLEX TRADING, LLC
13F
Company
0.16%
14,946
$20,000 30 Sep 2023
13F

Institutional Holders of Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) as of Q4 2023

As of 31 Dec 2023, Adicet Bio, Inc. - Common Stock, par value $0.0001 (ACET) was held by 76 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 33,363,531 shares. The largest 10 holders included ORBIMED ADVISORS LLC, RTW INVESTMENTS, LP, MORGAN STANLEY, COWEN AND COMPANY, LLC, BlackRock Inc., Carlyle Group Inc., VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, TANG CAPITAL MANAGEMENT LLC, and RENAISSANCE TECHNOLOGIES LLC. This page lists 76 institutional shareholders reporting positions in this security for the Q4 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2023 vs Q3 2023 Across Filers

Q3 2023 holders
83
Q4 2023 holders
76
Holder diff
-7
Investor Q3 2023 Shares Q4 2023 Shares Share Diff Share Chg % Q3 2023 Value $ Q4 2023 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .